Korea 2024 Outlook: Continued Focus On Drug Delivery Technologies

ADC, Long-Acting, SC Tech In Spotlight

 
• By Jung Won Shin

In a tough R&D environment, delivery technology-based new drug development activities by Korean firms are poised to remain robust in 2024.

Pill Injections
Korean Firms Pursuing Formulation Changes Of Global Blockbusters • Source: Shutterstock

More from South Korea

More from Focus On Asia